NCT04197141View on ClinicalTrials.gov

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 7, 2020

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

Conventionally-fractionated WPRT

Total dose: 45 Gy in 25 fractions WPRT

RADIATION

Hypofractionated WPRT

Total dose: 25 Gy in 5 fractions WPRT

Trial Locations (3)

T2N 4N2

Tom Baker Cancer Centre, Calgary

V1Y 5L3

BC Cancer, Kelowna

N6A 5W9

London Regional Cancer Program of the Lawson Health Research Institute, London

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

Canadian Association of Radiation Oncology

INDUSTRY

collaborator

AbbVie

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER